MR-less surface-based amyloid assessment based on11C PiB PET

PLoS ONE

Volumn 9, Issue 1, 2014, Pages

  Zhou, Luping ^a,c   Salvado, Olivier ^a   Dore, Vincent ^a   Bourgeat, Pierrick ^a   Raniga, Parnesh ^a   Macaulay, S Lance ^a   Ames, David ^d,e   Masters, Colin L ^d   Ellis, Kathryn A ^d   Villemagne, Victor L ^b   Rowe, Christopher C ^b   Fripp, Jurgen ^a  

^a CSIRO   (Australia)

^b AUSTIN HOSPITAL   (Australia)

^c UNIVERSITY OF WOLLONGONG   (Australia)

^d UNIVERSITY OF MELBOURNE   (Australia)

^e NATIONAL AGEING RESEARCH INSTITUTE   (Australia)

Author keywords

[No Author keywords available]

Indexed keywords

AMYLOID BETA PROTEIN; PITTSBURGH COMPOUND B;

ACCURACY; AGED; ARTICLE; CONTROLLED STUDY; FEMALE; GRAY MATTER; HUMAN; IMAGE ANALYSIS; INTERMETHOD COMPARISON; MAJOR CLINICAL STUDY; MALE; NUCLEAR MAGNETIC RESONANCE IMAGING; PET SCANNER; POSITRON EMISSION TOMOGRAPHY; REGISTER; SCORING SYSTEM; WHITE MATTER;

AGED; AGED, 80 AND OVER; ALZHEIMER DISEASE; AMYLOID BETA-PEPTIDES; BENZOTHIAZOLES; BRAIN; FEMALE; HUMANS; MAGNETIC RESONANCE IMAGING; MALE; MIDDLE AGED; PLAQUE, AMYLOID; POSITRON-EMISSION TOMOGRAPHY; REPRODUCIBILITY OF RESULTS;

EID: 84897554886     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0084777     Document Type: Article

References (40)

1. Aalto S, Scheinin MN, Kemppainen MN, Någren K, Kailajärvi M, et al. (2009) Reproducibility of automated simplified voxel-based analysis of PET amyloid ligand [11C]PIB uptake using 30-min scanning data. Eur J Nucl Med Mol Imaging 36: 1651-1660.
2. Acosta O, Fripp J, Doré V, Bourgeat P, Favreau JM, et al. (2012) Cortical surface mapping using topology correction, partial flattening and 3D shape context-based non-rigid registration for use in quantifying atrophy in Alzheimer's disease. Journal of Neuroscience Methods 205: 96-109.
3. Artaechevarria X, Munoz-Barrutia A, Ortiz-de-Solorzano C (2009) Combination strategies in multi-atlas image segmentation: application to brain MR data. IEEE Trans Med Imaging 28 (8): 1266-1277.
4. Bourgeat P, Raniga P, Dore V, Zhou L, Macaulay SL, et al. (2012) Manifold Driven MR-less PiB SUVR Normalisation. In MICCAI 2012 Workshop on Novel Imaging Biomarkers for Alzheimer's Disease and Related Disorders (NIBAD'12)
5. Braak H, Braak E (1991) Neuropathological stageing of Alzheimer-related changes. Acta Neuropathol. (Berl) 82 (4): 239-259.
6. Doré V, Fripp J, Bourgeat P, Shen K, Salvado O (2011) Surface-base Approach using a Multi-Scale EM-ICP Registration for Statistical Population Analysis. In Proceedings of the Digital Image Computing Techniques and Applications (DICTA) 2011:13-18.
7. Ellis KA, Bush AI, Darby D, De Fazio D, Foster J, et al. (2009) The Australian Imaging, Biomarkers and Lifestyle (AIBL) study of aging: methodology and baseline characteristics of 1112 individuals recruited for a longitudinal study of Alzheimer's disease. Int Psychogeriatr 21: 672-687.
8. Fripp J, Bourgeat P, Acosta O, Raniga P, Modat M, et al. (2008) Appearance modeling of 11C PiB PET images: characterizing amyloid deposition in Alzheimer's disease, mild cognitive impairment and healthy aging. Neuroimage 43 (3): 430-439.
9. Fodero-Tavoletti T, Rowe C, McLean A, Leone L, Li X, et al. (2009) Characterization of PiB binding to white matter in Alzheimer disease and other dementias. J Nucl Med. 50(2): 198-204.
10. Hammers A, Allom R, Koepp J, Free L, Myers R, et al. (2003) Three-dimensional maximum probability atlas of the human brain, with particular reference to the temporal lobe. Hum. Brain Mapp. 19(4): 224-247. (Pubitemid 36959351)
11. Jack CR Jr, Lowe VJ, Senjem ML, Weigand SD, Kemp BJ, et al. (2008) 11C PiB and structural MRI provide complementary information in imaging of Alzheimer's disease and amnestic mild cognitive impairment. Brain 131: 665-680. (Pubitemid 351294719)
12. Joachim C, Morris J, Selkoe D (1989) Diffuse senile plaques occur commonly in the cerebellum in Alzheimer's disease. American J. Pathol. 135 (2): 309-319. (Pubitemid 19240215)
13. Kemppainen M, Aalto S, Wilson IA, Nagren K, Helin S, et al. (2006) Voxel-based analysis of PET amyloid ligand [11C]PiB uptake in Alzheimer disease. Neurology 67: 1534-1535.
14. Kemppainen M, Aalto S, Wilson I, Nagren K, Helin S, et al. (2007) PET amyloid ligand [11C] PiB uptake is increased in mild cognitive impairment. Neurology 68 (5): 1603-1606. (Pubitemid 46717985)
15. Klunk E, Engler H, Nordberg A, Wang Y, Blomqvist G, et al. (2004) Imaging brain amyloid in Alzheimer's disease with Pittsburgh Compound-B. Ann. Neurol. 55 (3): 306-319. (Pubitemid 38269583)
16. Lilja, A., Thurfjell L., 2010. Tools for aiding in the diagnosis of neurodegenerative diseases. http://www.faqs.org/patents/app/20100080432
17. Li Y, Rinne JO, Mosconi L, Pirraglia E, Rusinek H, et al. (2008) Regional analysis of FDG and PIB-PET images in normal aging, mild cognitive impairment, and Alzheimer's disease. Eur. J. Nucl. Med. Mol. Imaging. 35 (12): 2169-2181.
18. Lopresti BJ, Klunk WE, Mathis CA, Hoge JA, Ziolko SK, et al. (2005) Simplified quantification of Pittsburgh Compound B amyloid imaging PET studies: a comparative analysis. J Nucl Med. 46 (12): 1959-1972. (Pubitemid 46657441)
19. Mazziotta J, Toga A, Evans A, Fox P, Lancaster J, et al. (2001) A probabilistic atlas and reference system for the human brain. Philos Trans R Soc Lond B Biol Sci 356: 1293-1322.
20. Ng S, Villemagne L, Berlangieri S, Lee T, Cherk M, et al. (2007) Visual assessment versus quantitative assessment of 11C-PiB PET and 18F-FDG PET for detection of Alzheimer's disease. J. Nucl. Med. 48 (4): 547-552. (Pubitemid 47571408)
21. Okello A, Koivunen J, Edison P, Archer A, Turkheimer E, et al. (2009) Conversion of amyloid positive and negative MCI to AD over 3 years: an 11C-PIB PET study. Neurology 73(10): 754-760.
22. Ourselin S, Roche A, Subsol G, Pennec X, Ayache N (2001) Reconstructing a 3D structure from serial histological sections. Image Vis. Comput. 19 (1): 25-31. (Pubitemid 32033991)
23. Raniga P, Bourgeat P, Fripp J, Acosta O, Ourselin S, et al. (2009) Alzheimer's disease detection using 11C-PiB with improved partial volume effect correction. In SPIE: Medical Imaging 2009.
24. Raniga P, Bourgeat P, Villemagne V, O'Keefe G, Rowe C, et al. (2007) PIB-PET Segmentation for Automatic SUVR Normalization Without MR Information. In Proceedings of IEEE International Symposium on Biomedical Imaging: From Nano to Macro (ISBI) 2007: 348-351.
25. Rousset OG, Ma Y, and Evans AC (1998) Correction for partial volume effects in PET: Principle and validation. Journal Nucl Med 39(5): 904-911. (Pubitemid 28216748)
26. Rowe CC, Ng S, Ackermann U, Gong J, Pike K, et al. (2007) Imaging beta-amyloid burden in aging and dementia. Neurology 68 (20): 1718-1725. (Pubitemid 46763260)
27. Rowe CC, Ellis KA, Rimajova M, Bourgeat P, Pike KE, et al. (2010) Amyloid imaging results from the Australian Imaging, Biomarker and Lifestyle (AIBL) study of aging. Neurobiol. Aging. 31: 1275.
28. Rueckert D, Sonoda LI, Hayes C, Hill DLG, Leach MO, et al. (1999) Nonrigid Registration Using Free-Form Deformations: Application to Breast MR Images. IEEE Trans. on Medical Imaging 18(8): 712-721. (Pubitemid 32262025)
29. Rueda A, Acosta O, Couprie M, Bourgeat P, Fripp J, et al. (2010) Topology-corrected segmentation and local intensity estimates for improved partial volume classification of brain cortex in MRI," J. Neurosci. Methods 188: 305-315.
30. Schott JM, Bartlett JW, Fox NC, Barnes J (2010) Increased brain atrophy rates in cognitively normal older adults with low cerebrospinal fluid Abeta1-42. Ann Neurol 68: 825-834.
31. Studholme C, Hill D, Hawkes D (1999) An overlap invariant entropy measure of 3D Medical image alignment. Pattern Recogn. 32 (1): 71-86.
32. Thal DR, Rüb U, Orantes M, Braak H (2002) Phases of Abeta-deposition in the human brain and its relevance for the development of AD. Neurology 58 (12): 1791-1800. (Pubitemid 34663580)
33. Thal DR, Capetillo-Zarate E, Del Tredici K, Braak H (2006) The development of amyloid beta protein deposits in the aged brain. Sci. Aging Knowledge Environ. 2006 (6).
34. 11C PIB studies in Alzheimer's disease. Eur J Nucl Med Mol Imaging 36(10): 1629-1638.
35. Tzourio-Mazoyer N, Landeau B, Papathanassiou D, Crivello F, Etard O, et al. (2002) Automated Anatomical Labeling of Activations in SPM Using a Macroscopic Anatomical Parcellation of the MNI MRI Single-Subject Brain. NeuroImage 15: 273-289. (Pubitemid 34852226)
36. Villemagne VL, Pike KE, Chételat G, Ellis KA, Mulligan RS, et al. (2011) Longitudinal Assessment of Ab and Cognition in Aging and Alzheimer Disease. Ann Neurol. 69(1): 181-192.
37. Villemagne VL, Ong K, Mulligan RS, Holl G, Pejoska S, et al. (2011) Amyloid imaging with 18F-florbetaben in Alzheimer disease and other dementias. J Nucl Med. 52:1210-1217.
38. Yasuno F, Hasnine H, Suhara T, Ichimiya T, Sudo Y, et al. (2002) Template-based method for multiple volumes of interest of human brain PET images. Neuroimage 16 (3 Pt. 1): 577-586. (Pubitemid 34852423)
39. Yotter RA, Doshi J, Clark V, Sojkova J, Zhou Y, et al. (2013) Memory decline shows stronger associations with estimated spatial patterns of amyloid deposition progression than total amyloid burden. Neurobiology of Aging. 34 (12): 2835-2842.
40. Ziolko K, Weissfeld A, Klunk E, Mathis A, Hoge A, et al. (2006) Evaluation of voxel-based methods for the statistical analysis of PiB PET amyloid imaging studies in Alzheimer's disease. Neuroimage 33 (1): 94-102.